SCHEMBL3801573

SCHEMBL3801573

CCCCCCCCCC[N]CC

nearest known ligand 0.52

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.52
TSHR P16473 4/20 0.50
THRB P10828 1/20 0.50
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
DNM1 Q05193 6/20 0.38
ALDH1A1 P00352 3/20 0.38
LMNA P02545 2/20 0.38
HSD17B10 Q99714 1/20 0.38
SLC22A1 O15245 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2435635 1.00 NAAA (0.52) NAAATSHRTHRBMEN1KMT2A
SCHEMBL271380 1.00
SCHEMBL303005 1.00 NAAA (0.52) NAAATSHRTHRBMEN1KMT2A
SCHEMBL4604995 1.00 NAAA (0.52) NAAATSHRTHRBMEN1KMT2A
SCHEMBL303477 1.00 NAAA (0.52) NAAATSHRTHRBMEN1KMT2A
SCHEMBL2536851 1.00 NAAA (0.52) NAAATSHRTHRBMEN1KMT2A
SCHEMBL56917 0.97
SCHEMBL9848564 0.94 NAAA (0.52) NAAATSHRTHRBMEN1KMT2A
SCHEMBL277225 0.90 TSHR (0.61) NAAATSHRTHRBMEN1KMT2A
SCHEMBL9206028 0.90 TSHR (0.61) NAAATSHRTHRBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9831042-B2 Organic dyes comprising a hydrazone moiety and their use in dye-sensitized solar cells BASF SE (DE) 2017-11-28 US disclosed
US-20160126022-A1 ORGANIC DYES COMPRISING A HYDRAZONE MOIETY AND THEIR USE IN DYE-SENSITIZED SOLAR CELLS BASF SE (DE) 2016-05-05 US disclosed
EP-2870204-A2 ORGANIC DYES COMPRISING A HYDRAZONE MOIETY AND THEIR USE IN DYE-SENSITIZED SOLAR CELLS BASF SE (DE) 2015-05-13 EP disclosed
WO-2014006544-A2 ORGANIC DYES COMPRISING A HYDRAZONE MOIETY AND THEIR USE IN DYE-SENSITIZED SOLAR CELLS BASF SE (DE) 2014-01-09 WO disclosed
US-20100140559-A1 MIXTURES FOR PRODUCING PHOTOACTIVE LAYERS FOR ORGANIC SOLAR CELLS AND ORGANIC PHOTODETECTORS BASF SE (DE) 2010-06-10 US disclosed
US-20070191420-A1 Kinase inhibitors DEVGEN NV 2007-08-16 US disclosed
EP-1715862-A1 KINASE INHIBITORS Devgen NV (BE) 2006-11-02 EP disclosed
WO-2005082367-A1 KINASE INHIBITORS DEVGEN NV (BE) 2005-09-09 WO disclosed
EP-0983277-B1 POLYBORATE COINITIATORS FOR PHOTOPOLYMERIZATION CIBA SC HOLDING AG (CH) 2003-01-22 EP disclosed
US-6087062-A COINITIATOR INCLUDING ELECTRON ACCEPTOR COMPOUND; EFFICIENCY, PHOTOSENSITIVITY CIBA SPECIALTY CHEMICALS CORPORATION (US) 2000-07-11 US disclosed
EP-0983277-A1 POLYBORATE COINITIATORS FOR PHOTOPOLYMERIZATION Ciba SC Holding AG (CH) 2000-03-08 EP disclosed
WO-1998052952-A1 POLYBORATE COINITIATORS FOR PHOTOPOLYMERIZATION CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1998-11-26 WO disclosed
US-5354729-A Controlling weeds at low dosage; nonphytotoxic SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1994-10-11 US disclosed
EP-0579469-A2 N-acyldihydroquinoline derivatives as herbicides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1994-01-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160126022-A1 ORGANIC DYES COMPRISING A HYDRAZONE MOIETY AND THEIR USE IN DYE-SENSITIZED SOLAR CELLS C1S, C9, C1R NAAA 4547/4885TSHR 4121/4885THRB 4527/4885
US-20070191420-A1 Kinase inhibitors ROCK1, ROCK2, MAP3K20 NAAA 3921/4885TSHR 3553/4885THRB 2167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.